Curamir Therapeutics

About:

Curamir Therapeutics is a developer of miRNA-based cancer therapeutics.

Website: https://curamirtherapeutics.com/

Top Investors: Delos Capital

Description:

Curamir is a Woburn, MA-based biotechnology company launched and incubated by Delos Capital with an initial academic licensing from SUNY. Through its proprietary miRNA engineering platform and insights into cancer biology, Curamir develops miRNA-based cancer therapeutics with enhanced safety, potency and stability. Its novel approach addresses current challenges associated with both chemoresistance in cancer and effective systemic delivery of miRNA mimics.